🔎 Trials Near Me

Hjem › Metastatisk kreft › Texas › Austin

Kliniske studier for Metastatisk kreft i Austin, TX

19 studier for Metastatisk kreft søker deltakere på steder i og rundt Austin (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

RekruttererFase 1/2
  • Avenzo Therapeutics Recruiting Site, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07193511

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

RekruttererFase 3
  • Texas Oncology - Austin, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07562152

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

RekruttererFase 1
  • NEXT Austin, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06270706

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

RekruttererFase 1/2
  • New Experimental Therapeutics - NEXT Oncology, Austin
Alder 12 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

RekruttererFase 1
  • NEXT Oncology, Austin
Alder 19 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06586957

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

RekruttererFase 1
  • NEXT Oncology, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07612176

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

RekruttererFase 3
  • Texas Oncology - Central/South Texas, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07222566

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

RekruttererFase 3
  • USO-Texas Oncology-Central/South Texas, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

RekruttererFase 3
  • USO-Texas Oncology-Central/South Texas, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07218380

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

RekruttererFase 1/2
  • Texas Oncology (Balcones) - SCRI, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT05267626

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

RekruttererFase 1/2
  • Texas Oncology - Central South, Austin
  • Texas Oncology - Central South, Austin
  • Texas Oncology - Central South, Austin
  • og 1 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07227415

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

RekruttererFase 1/2
  • NEXT Oncology - Austin, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT06566079

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • USO - Texas Oncology, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

RekruttererFase 1/2
  • Crinetics Study Site, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT07129252

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

RekruttererFase 1/2
  • Texas Oncology - Central/South Texas, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jul. 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

RekruttererFase 3
  • Research Site, Austin
Alder 18 og eldre · Kvinner · Oppdatert 29. jul. 2026 · NCT07044336

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

RekruttererFase 1
  • Texas Oncology - Central South, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT06657144

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

RekruttererFase 1/2
  • University of Texas at Austin, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 15. mai 2026 · NCT05379985

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

RekruttererFase 1/2
  • NEXT Austin, Austin
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jan. 2025 · NCT06090266

Metastatisk kreft-studier i andre byer

Andre studier i Austin

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.